Seres Therapeutics, Inc. Shares Outstanding (Cover Page)
Seres Therapeutics, Inc. (MCRB) had Shares Outstanding (Cover Page) of 9.94 million shares as of 2026-08-03, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-08-03: Entity Common Stock, Shares Outstanding 9.94M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 9.59M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 9.05M shares.
- 2025-08-01: Entity Common Stock, Shares Outstanding 8.75M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 9.94M shares 10-Q · filed 2026-08-05 |
| 2026-03-06 | 9.59M shares 10-K · filed 2026-03-12 |
| 2025-10-31 | 9.05M shares 10-Q · filed 2025-11-05 |
| 2025-08-01 | 8.75M shares 10-Q · filed 2025-08-06 |
| 2025-05-02 | 8.73M shares 10-Q · filed 2025-05-07 |
| 2025-03-07 | 174.36M shares 10-K · filed 2025-03-13 |
| 2024-11-08 | 170.74M shares 10-Q · filed 2024-11-13 |
| 2024-08-09 | 151.73M shares 10-Q · filed 2024-08-13 |
| 2024-05-06 | 151.45M shares 10-Q · filed 2024-05-08 |
| 2024-03-01 | 151.01M shares 10-K · filed 2024-03-05 |
| 2023-10-30 | 129.26M shares 10-Q · filed 2023-11-02 |
| 2023-08-04 | 128.20M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 127.90M shares 10-Q · filed 2023-05-09 |
| 2023-03-03 | 126.08M shares 10-K · filed 2023-03-07 |
| 2022-10-28 | 124.59M shares 10-Q · filed 2022-11-02 |
| 2022-08-01 | 124.07M shares 10-Q · filed 2022-08-03 |
| 2022-04-27 | 92.23M shares 10-Q · filed 2022-05-04 |
| 2022-02-24 | 92.01M shares 10-K · filed 2022-03-01 |
| 2021-11-03 | 91.85M shares 10-Q · filed 2021-11-10 |
| 2021-07-28 | 91.72M shares 10-Q · filed 2021-08-03 |
| 2021-04-28 | 91.62M shares 10-Q · filed 2021-05-04 |
| 2021-02-24 | 91.55M shares 10-K · filed 2021-03-02 |
| 2020-11-03 | 91.25M shares 10-Q · filed 2020-11-09 |
| 2020-07-22 | 76.26M shares 10-Q · filed 2020-07-28 |
| 2020-05-01 | 72.60M shares 10-Q · filed 2020-05-07 |
| 2020-02-25 | 71.07M shares 10-K · filed 2020-03-02 |
| 2019-10-29 | 69.99M shares 10-Q · filed 2019-11-05 |
| 2019-07-31 | 69.91M shares 10-Q · filed 2019-08-06 |
| 2019-04-24 | 41.09M shares 10-Q · filed 2019-05-02 |
| 2019-02-28 | 41.05M shares 10-K · filed 2019-03-06 |
| 2018-11-02 | 40.86M shares 10-Q · filed 2018-11-08 |
| 2018-07-26 | 40.80M shares 10-Q · filed 2018-08-02 |
| 2018-05-03 | 40.65M shares 10-Q · filed 2018-05-09 |
| 2018-03-02 | 40.65M shares 10-K · filed 2018-03-08 |
| 2017-11-03 | 40.53M shares 10-Q · filed 2017-11-08 |
| 2017-07-31 | 40.51M shares 10-Q · filed 2017-08-03 |
| 2017-05-01 | 40.39M shares 10-Q · filed 2017-05-04 |
| 2017-03-10 | 40.37M shares 10-K · filed 2017-03-16 |
| 2016-11-07 | 40.36M shares 10-Q · filed 2016-11-10 |
| 2016-08-05 | 40.27M shares 10-Q · filed 2016-08-11 |
| 2016-05-09 | 39.52M shares 10-Q · filed 2016-05-16 |
| 2016-03-07 | 39.19M shares 10-K · filed 2016-03-14 |
| 2015-11-06 | 39.06M shares 10-Q · filed 2015-11-12 |
| 2015-08-07 | 38.96M shares 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |